Business

Recently, a federal judge in New Jersey made a significant ruling regarding Johnson & Johnson’s and Bristol Myers Squibb’s legal challenges to the Biden administration’s Medicare drug-price negotiations. The decision is a blow to the pharmaceutical industry’s attempts to challenge the constitutionality of the program, which is a key policy under President Joe Biden’s Inflation
0 Comments
The approval of Wegovy for heart health in the U.S. opens up the possibility of coverage for more than 3 million people with Medicare, according to a recent analysis by the health policy research organization KFF. This milestone could significantly impact the healthcare landscape for eligible beneficiaries, but challenges remain in terms of out-of-pocket costs
0 Comments
PepsiCo recently released their quarterly earnings report, exceeding analysts’ expectations despite facing challenges such as weaker U.S. demand due to recalls and higher prices. The company reported earnings per share of $1.61, surpassing the expected $1.52, and revenue of $18.25 billion, higher than the predicted $18.07 billion. Net income attributable to the company also increased
0 Comments